Harvard Bioscience (HBIO) Acquisitions (2010 - 2018)

Harvard Bioscience's (HBIO) quarterly Acquisitions came in at $540000.0 in Q4 2018, down 9.24% on a QoQ basis from $595000.0 in Q2 2018.

Harvard Bioscience (HBIO) Acquisitions (2010 - 2018) Analysis & Trends

Harvard Bioscience (HBIO) has 6 years of Acquisitions data on file, last reported at $540000.0 in Q4 2018.

On a quarterly basis, Acquisitions changed N/A year-over-year to $540000.0 in Q4 2018; TTM through Sep 2019 was $540000.0, a 99.21% decrease from a year earlier, with the FY2018 full-year figure at $68.5 million, changed N/A from the prior year.
Acquisitions for Q4 2018 stood at $540000.0, down from $595000.0 in the prior quarter.
Over the last five years, Acquisitions for HBIO reached as high as $67.4 million in Q1 2018 and fell as low as $540000.0 in Q4 2018.
Historically, Acquisitions has averaged $17.1 million across 3 years, with a median of $4.5 million in 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	24.88 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	-
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	-
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	18.96 Mn
10	Harvard Bioscience	28.05 Mn	20.96 Mn	12.24 Mn	-

Download Data